[Antipuritic therapy with naltrexone].
D000284:Administration, Oral; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002986:Clinical Trials as Topic; D004305:Dose-Response Relationship, Drug; D005260:Female; D005767:Gastrointestinal Diseases / Q000139:chemically induced; D006801:Humans; D008297:Male; D008875:Middle Aged; D009271:Naltrexone / Q000008:administration & dosage* / Q000009:adverse effects; D009292:Narcotic Antagonists / Q000008:administration & dosage; D009422:Nervous System Diseases / Q000139:chemically induced; D011537:Pruritus / Q000188:drug therapy*; D013618:Tachyphylaxis; D016896:Treatment Outcome
D009292:Narcotic Antagonists; D009271:Naltrexone